Current Concepts in Management of Vestibular Schwannomas in Neurofibromatosis Type 2 (original) (raw)
Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients
Vanessa Merker
Otology & Neurotology, 2014
View PDFchevron_right
A clinical study of vestibular schwannomas in type 2 neurofibromatosis
Ameet Kishore
Clinical Otolaryngology and Allied Sciences, 2000
View PDFchevron_right
Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations
Yaser Ghavami
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015
View PDFchevron_right
Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas
Patrick Hanssens
Journal of Neurosurgery, 2017
View PDFchevron_right
Bevacizumab Treatment for Vestibular Schwannoma in a Patient with Neurofibromatosis Type 2: Hearing Improvement and Tumor Shrinkage
David Rondonotti
Tumori Journal, 2015
View PDFchevron_right
A systematic review of radiosurgery versus surgery for neurofibromatosis type 2 vestibular schwannomas
Thiên Phước Nguyễn
World neurosurgery, 2017
View PDFchevron_right
Bevacizumab in Neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation
Rosalie Ferner
Neuro-Oncology Practice, 2016
View PDFchevron_right
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2
Vanessa Merker
Otology & Neurotology, 2012
View PDFchevron_right
Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2
Manish Sharma
Journal of Neuro-Oncology, 2010
View PDFchevron_right
Three-Fraction Stereotactic Radiosurgery for Treatment of Vestibular Schwannoma (Acoustic Neuroma) in Patients with Neurofibromatosis Type 2
John Adler
Journal of Radiosurgery, 1999
View PDFchevron_right
Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas
John Butman
Neuro-oncology, 2014
View PDFchevron_right
Fractionated stereotactic radiotherapy for bilateral vestibular schwannomas associated with neurofibromatosis type 2: early experiences in Ramathibodi Hospital
Pornpan Yong
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2004
View PDFchevron_right
Progress of hearing loss in neurofibromatosis type 2: implications for future management
Simon Freeman
European Archives of Oto-Rhino-Laryngology, 2014
View PDFchevron_right
Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2
Daniel Roos
Journal of Clinical Neuroscience, 2008
View PDFchevron_right
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2
Rosalie Ferner
American Journal of Medical Genetics Part A, 2012
View PDFchevron_right
The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2
Michael Slancar
Australasian Journal of Neuroscience, 2021
View PDFchevron_right
Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
Soma Sengupta
International Journal of Molecular Sciences, 2021
View PDFchevron_right
EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma
Otologia Joan XXIII
View PDFchevron_right
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Vanessa Merker
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
View PDFchevron_right
Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature
Andras Kemeny
British Journal of Neurosurgery, 2002
View PDFchevron_right
Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis
Lee Walton
Journal of Neurology, Neurosurgery & Psychiatry, 2003
View PDFchevron_right
Neurofibromatosis type 2: case report
Tadeusz Mendel
Postepy Psychiatrii I Neurologii, 2013
View PDFchevron_right
Acoustic Neuroma (Vestibular Schwannoma) Revision
Richard Wiet
Otolaryngologic Clinics of North America, 2006
View PDFchevron_right
MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools
Johannes A. Koeppen
Scientific Reports, 2020
View PDFchevron_right
Clinicopathologic Assay of 15 Tumor Resections in a Family with Neurofibromatosis Type 2
Gordana Juric-Sekhar
Journal of Neurological Surgery Part B: Skull Base, 2012
View PDFchevron_right
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
Timothy Padera
New England Journal of Medicine, 2009
View PDFchevron_right
Metachronous Bilateral Vestibular Schwannomas
Renato Torres
The Laryngoscope, 2020
View PDFchevron_right
Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2
Brian Subach
Journal of Neurosurgery, 1999
View PDFchevron_right
Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients
KENSHO IWATATE
Neurologia medico-chirurgica
View PDFchevron_right
First Place—Resident Clinical Science Award 1997: Germline screening of the NF-2 gene in families with unilateral vestibular schwannoma
Ali Surosh Attaie
Otolaryngology–Head and Neck Surgery, 1998
View PDFchevron_right
Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2
Vianney Gaillard
Journal of Neuro-Oncology, 2015
View PDFchevron_right